Accès ouvert

Review of: "The potential of GLP-1 RAs in treating Tobacco use dependence and Obesity"

Article scientifique 2023 Anglais

Résumé

Glucagon-like peptide-1 receptor agonists (GLP-1-RAs) are a class of type 2 diabetes drugs that regulate blood glucose while reducing weight gain. Recent research have shown the potential of GLP-1-RAs to abet smoking abstinence. 'The potential of GLP-1 RAs in treating Tobacco use dependence and Obesity' reported by Kok Kuan et al is a very interesting and well conceptualized review manuscript which creates a focal point for robust future studies on GLP-1R agonists.

Citer ce document

Salau, V. (2023). Review of: "The potential of GLP-1 RAs in treating Tobacco use dependence and Obesity". https://doi.org/10.32388/z3aydz

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Auteur(s)

Veronica F. Salau

Statistiques

Consultations : 1

Téléchargements : 0